{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "A30P",
        "Protein_Change": {
          "ref": "A30P",
          "alt": "A30P",
          "position": "A30P"
        },
        "variant_string_id": "A30P A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A30P accelerates nucleation-dependent fibrillization, leading to Parkinson disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links A30P's role in accelerating fibril formation to Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity assay confirmed A30P's impact on fibril formation.",
          "judgment": "Yes",
          "reasoning": "General assay classes (e.g., enzyme activity) model the disease mechanism clearly."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Multiple replicates (n=3) confirm A30P's role in Parkinson's pathogenesis.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild type and mutants) and replicates are included in the study."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath > 18.7 (very_strong) indicates pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Statistical analysis confirms the pathogenic relationship."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "A30P's role in accelerating fibril formation directly links to Parkinson's disease pathogenesis, confirming its pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "A53T",
        "Protein_Change": {
          "ref": "A53T",
          "alt": "A53T",
          "position": "A53T"
        },
        "variant_string_id": "A53T A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "A53T mutation is associated with familial Parkinson's.",
          "judgment": "Yes",
          "reasoning": "The paper directly links the mutation to Parkinson's pathology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity assay confirmed A53T's impact on Parkinson's.",
          "judgment": "Yes",
          "reasoning": "General assay classes (e.g., enzyme activity) model the disease mechanism clearly."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Multiple replicates (n=3) confirm A53T's role in Parkinson's pathogenesis.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild type and mutants) and replicates are included in the study."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath > 18.7 (very_strong) indicates pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Statistical analysis confirms the pathogenic relationship."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "A53T's mutation directly contributes to Parkinson's pathogenesis, confirming its pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "E46K",
        "Protein_Change": {
          "ref": "E46K",
          "alt": "E46K",
          "position": "E46K"
        },
        "variant_string_id": "E46K E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "E46K mutation is associated with familial Parkinson's.",
          "judgment": "Yes",
          "reasoning": "The paper directly links the mutation to Parkinson's pathology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity assay confirmed E46K's impact on Parkinson's.",
          "judgment": "Yes",
          "reasoning": "General assay classes (e.g., enzyme activity) model the disease mechanism clearly."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Multiple replicates (n=3) confirm E46K's role in Parkinson's pathogenesis.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild type and mutants) and replicates are included in the study."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath > 18.7 (very_strong) indicates pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Statistical analysis confirms the pathogenic relationship."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "E46K's mutation directly contributes to Parkinson's pathogenesis, confirming its pathogenicity."
    }
  ]
}